Skip to main content
Novonesis AS logo

Novonesis AS — Investor Relations & Filings

Ticker · NSIS ISIN · DK0060336014 LEI · 529900T6WNZXD2R3JW38 CO Manufacturing
Open in API
Filings indexed 2,308 across all filing types
Latest filing 2017-03-13 Transaction in Own Shar…
Country DK Denmark
Listing CO NSIS

About Novonesis AS

https://www.novozymes.com/en

Novonesis is a global biosolutions company formed through the combination of Novozymes and Chr. Hansen. The company develops and produces a broad portfolio of biological solutions, including industrial enzymes, functional proteins, and microorganisms such as cultures, probiotics, and yeast. Its products are utilized in over 30 industries to improve efficiency, sustainability, and product quality. Key markets include food and beverage, where solutions enhance nutrition and reduce waste; human and animal health; agriculture, promoting higher crop yields and animal welfare; and household care, for more effective cleaning. Novonesis applies biotechnological principles to address global challenges in production and consumption, aiming to create more sustainable systems and products.

Recent filings

Filing Released Lang Actions
Transaktioner i forbindelse med Novozymes’ aktietilbagekøbsprogram
Transaction in Own Shares Classification · 85% confidence The text describes accumulated share purchases by the company under its announced stock buyback program, i.e., the company’s own share transactions. This clearly matches the “Transaction in Own Shares” category (POS).
2017-03-13 English
Transaction in Own Shares 2017
Transaction in Own Shares Classification · 100% confidence The document text is very short (260 characters) and describes a transaction where Novozymes bought back shares under a previously announced share repurchase program. The key phrase is 'købt i alt 971.491 aktier' (bought a total of 971,491 shares) related to a 'aktietilbagekøbsprogram' (share repurchase program). This directly corresponds to the definition of 'Transaction in Own Shares' (POS). The final line 'Læs hele meddelelsen i PDF format' suggests this is a brief announcement, but the content itself is a direct report of the transaction, making POS the most accurate classification over RPA/RNS.
2017-03-06 Danish
Transaction in Own Shares 2017
Transaction in Own Shares Classification · 100% confidence The document text explicitly states that Novozymes has purchased an accumulated number of shares under a 'stock buyback program' announced previously. This action—the company buying back its own shares—directly corresponds to the definition of 'Transaction in Own Shares'. The document length is very short (274 chars) and mentions reading the full announcement in PDF, which might suggest RPA, but the core content is a direct report of a share transaction, making POS the most specific fit over the general RPA/RNS fallback.
2017-03-06 English
Transaktioner i forbindelse med Novozymes’ aktietilbagekøbsprogram
Transaction in Own Shares Classification · 95% confidence The document is a company announcement detailing transactions related to Novozymes' share buy-back program, including specific dates, number of shares bought, prices, and total transaction values. It references compliance with EU regulations on market abuse and provides detailed trading data. There is no indication of financial statements, earnings data, management discussion, or other report content. The document is a regulatory announcement about share repurchases, not a financial report or earnings release. Therefore, it fits the category of Transaction in Own Shares (POS). The document length is substantial and contains detailed transaction data, supporting a high confidence in classification.
2017-03-06 English
Transaktioner i forbindelse med Novozymes’ aktietilbagekøbsprogram
Transaction in Own Shares Classification · 95% confidence The document is a detailed announcement of transactions under Novozymes' stock buyback program, including number of shares purchased, transaction values, and trading data. It references a specific stock buyback program initiated in 2017 and provides detailed trading data for several days. There is no indication of financial statements, management discussion, or earnings data. The content is focused on share repurchase activity, which fits the category of a company buying back its own shares. The document is not a full financial report, earnings release, or regulatory filing about other matters. Therefore, the appropriate classification is Transaction in Own Shares (POS). The document length and detail support a high confidence in this classification.
2017-03-06 English
Transaction in Own Shares 2017
Transaction in Own Shares Classification · 100% confidence The document text explicitly states that Novozymes has purchased an accumulated number of shares under a 'stock buyback program'. This action directly relates to the company trading its own shares. The filing category 'Transaction in Own Shares (POS)' is defined as the report of the company buying back or selling its own shares. Although it mentions reading the full announcement in PDF, the core content is the transaction update itself, making POS the most specific fit over a general RPA or RNS, given the short length and direct nature of the update.
2017-02-27 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.